Cellectis (CLLS) EBITDA Margin (2015 - 2026)
Cellectis (CLLS) posted quarterly EBITDA Margin of 435.64% for Q1 2026, down 30257.0% year-over-year from N/an in Q1 2025, and down 219.25% quarter-over-quarter from 136.46% in Q4 2025.
Cellectis (CLLS) EBITDA Margin (2015 - 2026) Analysis & Trends
Cellectis' EBITDA Margin history runs 12 years deep, the most recent figure standing at 435.64% for Q1 2026.
- In Q1 2026, EBITDA Margin fell 30257.0% year-over-year to 435.64%; the TTM figure through Mar 2026 stood at 62.6% (up 3287.0% YoY), while the FY2025 annual figure was 81.64%, up 3937.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 435.64%, down from 136.46% in the prior quarter.
- The five-year high for EBITDA Margin was 22.86% in Q3 2025, with the low at 16856.83% in Q1 2023.
- The 5-year median for EBITDA Margin is 339.17% (2023), against an average of 3814.5%.
- The sharpest annual moves came in 2022 and 2024: EBITDA Margin sank 1512056 bps in 2022, then surged 1639539 bps in 2024.
- Cellectis' EBITDA Margin stood at 35.32% in 2022, then slumped by 860 bps to 339.17% in 2023, then soared by 85 bps to 52.28% in 2024, then sank by 161 bps to 136.46% in 2025, then tumbled by 219 bps to 435.64% in 2026.
- Business Quant data shows CLLS's EBITDA Margin at 435.64% in Q1 2026, 136.46% in Q4 2025, and 22.86% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 31.68% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.06% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -77,569,866.34% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.75% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 17.93% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.36% |
| 10 | Cellectis | 306.61 Mn | 120.95 Mn | - | -435.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -435.64% |
| Dec 31, 2025 | -136.46% |
| Sep 30, 2025 | 22.86% |
| Jun 30, 2025 | -57.32% |
| Mar 31, 2025 | -133.07% |
| Dec 31, 2024 | -52.28% |
| Sep 30, 2024 | -66.48% |
| Jun 30, 2024 | -213.51% |
| Mar 31, 2024 | -461.44% |
| Dec 31, 2023 | -339.17% |
| Sep 30, 2023 | -13,336.13% |
| Jun 30, 2023 | -13,270.22% |
| Mar 31, 2023 | -16,856.83% |
| Dec 31, 2022 | -35.32% |
| Sep 30, 2022 | -15,630.29% |
| Jun 30, 2022 | -2,089.75% |
| Mar 31, 2022 | -1,755.44% |
| Dec 31, 2021 | -239.33% |
| Sep 30, 2021 | -509.72% |
| Jun 30, 2021 | -335.37% |